NCT02124278View on ClinicalTrials.gov

Safety and Tolerability of Single Ascending Doses of PUL-042 Inhalation Solution in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions
Healthy
Interventions
DRUG

PUL-042 Inhalation Solution

Trial Locations (1)

77027

ICON Development Solutions, San Antonio

All Listed Sponsors
lead

Pulmotect, Inc.

INDUSTRY

NCT02124278 - Safety and Tolerability of Single Ascending Doses of PUL-042 Inhalation Solution in Healthy Subjects | Biotech Hunter | Biotech Hunter